EP1687026
METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITING IL-17 ACTIVITY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.11.2004EP published:
14.5.2008EP application number:
04798568.4
EPO information:
European Patent Register
Max expiry date:
15.11.2024
Title:
METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITING IL-17 ACTIVITY
Timeline
Today
16.11.2004EP application
14.5.2008EP Publication
Owner
Name:
UCB Pharma, S.A.Address:
Allée de La Recherche 60, 1070, Brussels, BE
Inventor
Name:
CHRISTIE, Mark Ian,Celltech R & D LimitedAddress:
Slough,Berkshire SL1 3WE, GB
Name:
MEAD, Richard James,Celltech R & D LimitedAddress:
Slough,Berkshire SL1 3WE, GB
Name:
ROBINSON, Martyn Kim,Celltech R & D LimitedAddress:
Slough,Berkshire SL1 3WE, GB
Name:
RAPECKI, Stephen Edward,Celltech R & D LimitedAddress:
Slough,Berkshire SL1 3WE, GB
Priority
Number:
0327181Date:
21.11.2003Country:
GB
Number:
0417115Date:
30.7.2004Country:
GB